A carregar...
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Anti-angiogenic therapy with bevacizumab, an inhibitor of vascular endothelial growth factor, is commonly used in metastatic colorectal cancer and is rarely associated with gastrointestinal perforation, perforation being more frequent in the primary tumor site or at the anastomotic level. We present...
Na minha lista:
| Publicado no: | GE Port J Gastroenterol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731107/ https://ncbi.nlm.nih.gov/pubmed/29255770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000479234 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|